T-helper cell responses to HIV envelope peptides in cord blood: Protection against intrapartum and breast-feeding transmission

AIDS

Volumn 15, Issue 1, 2001, Pages 1-9

  Kuhn, Louise ^a,b   Coutsoudis, Anna ^c   Moodley, Derseree ^c   Trabattoni, Daria ^d   Mngqundaniso, Nolwandle ^c   Shearer, Gene M ^e   Clerici, Mario ^d   Coovadia, Hoosen M ^c   Stein, Zena ^a,b  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^b University of Natal ^*  (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF MILAN   (Italy)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast feeding; Interleukin 2; Maternal infant HIV transmission; T helper responses

Indexed keywords

CYTOKINE; INTERLEUKIN 2; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; BIOASSAY; BREAST FEEDING; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFANT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PEPTIDE ANALYSIS; PLACENTAL TRANSFER; PRIORITY JOURNAL; RISK FACTOR; SOUTH AFRICA; UMBILICAL CORD BLOOD; VIRUS TRANSMISSION;

ANIMALS; BREAST FEEDING; CELL DIVISION; CELL LINE; CELLS, CULTURED; FEMALE; FETAL BLOOD; GENE PRODUCTS, ENV; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; MICE; PEPTIDES; PHYTOHEMAGGLUTININS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 0035808590     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200101050-00003     Document Type: Article

References (50)

1. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1
2. Exposure to human immunodeficiency virus type 1-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies
3. Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: Evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects
4. Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope
5. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients
6. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
7. Human Immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons
8. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
9. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers
10. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
11. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood
12. Cellular immune factors associated with mother-to-infant transmission of HIV
13. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children
14. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant
15. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1-infected mothers
16. Protective role of B-chemokines associated with HIV-specific Th responses against perinatal HIV transmission
17. Randomised trial testing effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child transmission of HIV-1 in Durban, South Africa
18. Influence of infant feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa
19. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals
20. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types
21. T cell multideterminant regions in the human immunodeficiency virus envelop: Toward overcoming the problem of major histocompatibility complex restriction
22. Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelop protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide
23. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infections
24. Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages
25. Workshop Report from the European Commission (DG XII,INCO-DC) and the Joint United Nations Program on HIV/AIDS: HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines and diagnostics
26. Vigorous HIV- 1-specific CD4+ T cell responses associated with control of viremia
27. Timing of maternal-infant HIV transmission: Associations between intrapartum factors and early polymerase chain reaction results
28. Proposed definitions for in utero versus intrapartum transmission of HIV-1
29. Sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period
30. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission
31. Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method
32. Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture
33. Frequent and early in utero HIV-1 infection
34. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester
35. Maternofetal transmission of AIDS: Frequency of human immunodeficiency virus type 1 nucleic acid sequences in human fetal DNA
36. Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection
37. HIV-1 proviral DNA polymerase chain reaction detection in chorionic villi after exclusion of maternal contamination by variable number of tandem repeats analysis
38. Genetic evaluation of suspected cases of transient HIV-1 infection of infants
39. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission
40. Mother-to-infant transmission of HIV type 1: Role of major histocompatibility antigen differences
41. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1
42. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
43. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
44. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
45. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
46. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
47. Global distribution of the CCR5 gene 32-basepair deletion
48. Demonstration of human T lymphotropic virus type I (HTLV-I)-specific T cell responses from seronegative and polymerase chain reaction-negative persons exposed to HTLV-I
49. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection